🔎 Trials Near Me

Início › Cânceres gastrointestinais › Texas

Ensaios clínicos de Cânceres gastrointestinais em Texas

26 estudos para Cânceres gastrointestinais estão buscando participantes em locais em Texas.

Cidades em Texas

Texto oficial do estudo (Inglês)

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

  • The University of Texas MD Anderson Cancer Center - Texas Medical Center, Houston
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT06760819

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

  • Texas Oncology - West Texas, Abilene
  • Texas Oncology - West Texas, Amarillo
  • Texas Oncology - Gulf Coast, Beaumont
  • e mais 27
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT07222800

DESTINY-PANTUMOUR04

  • Research Site, Dallas
RecrutandoEstudo observacional
Idades de 18 a 130 · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT07124000

A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy

  • GSK Investigational Site, Dallas
  • GSK Investigational Site, Houston
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT07218926

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

  • MD Anderson, Houston
  • NEXT Dallas, Irving
  • NEXT Oncology San Antonio, San Antonio
  • e mais 1
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT06128551

Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

  • Baylor College of Medicine, Houston
  • The University of Texas MD Anderson Cancer Center, Houston
  • NEXT Oncology Dallas, Irving
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT06445062

Study to Assess the Efficacy and Safety of Rina-S in Participants With Advanced Gastrointestinal (GI) Cancers

  • START San Antonio, San Antonio
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 9 de set. de 2026 · NCT07539311

Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma

  • START San Antonio, San Antonio
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 27 de ago. de 2026 · NCT06582017

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

  • The University of Texas, MD Anderson Cancer Center, Houston
  • UT Health Mays Cancer Center, San Antonio
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 11 de ago. de 2026 · NCT05592626

A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed (EMBOLD PanGI-201)

  • GSK Investigational Site, Houston
  • GSK Investigational Site, San Antonio
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 3 de ago. de 2026 · NCT06885034

Evaluation of Portal Vein Stenting in Patients With Portal Vein Stenosis and Gastrointestinal Cancers

  • M D Anderson Cancer Center, Houston
RecrutandoEstudo observacional
Idades 18 e acima · Todos os sexos · Atualizado em 21 de jul. de 2026 · NCT04629677

Goals of Care Discussion for Patients With Advanced Lung and Gastrointestinal Cancer in the Emergency Department of a Comprehensive Cancer Center

  • MD Anderson Cancer Center, Houston
Recrutando
Idades 18 e acima · Todos os sexos · Atualizado em 14 de jul. de 2026 · NCT06420206

A First in Human Study of PLT012 in Participants With Solid Tumor Cancers

  • NEXT Dallas, Dallas
  • MD Anderson Cancer Center, Houston
  • NEXT Houston, Houston
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 7 de jul. de 2026 · NCT07337525

Telephone Support in Advanced Gastrointestinal Cancer

  • MD Anderson Cancer Center, Houston
Recrutando
Idades 18 e acima · Todos os sexos · Atualizado em 6 de jul. de 2026 · NCT06532877

Improving Comprehensive Care of Cancer Patients

  • Baylor College of Medicine, Houston
RecrutandoVoluntários saudáveis bem-vindos
Idades 18 e acima · Todos os sexos · Atualizado em 30 de jun. de 2026 · NCT05323409

BOLSTER: Learning New Skills to Thrive

  • The University of Texas MD Anderson Cancer Center, Houston
Recrutando
Idades 18 e acima · Todos os sexos · Atualizado em 18 de jun. de 2026 · NCT06936878

Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy

  • M D Anderson Cancer Center, Houston
RecrutandoEstudo observacional
Idades 18 e acima · Todos os sexos · Atualizado em 12 de jun. de 2026 · NCT00991094

Single Dose Investigator Initiated Pilot Study to Investigate CYTALUX (Pafolacianine) for Intraoperative Detection of Malignant Tissue in Subjects Undergoing Surgical Resection for Cancer.

  • Clemments University Hospital, Dallas
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 5 de jun. de 2026 · NCT07039526

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

  • Sarah Cannon Research Institute at Mary Crowley, Dallas
  • University of Texas, MD Anderson Cancer Center, Houston
  • START, San Antonio
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 3 de jun. de 2026 · NCT06040541

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

  • UT Southwestern Medical Center, Dallas
  • MD Anderson Cancer Center, Houston
RecrutandoFase 1/2
Idades 12 e acima · Todos os sexos · Atualizado em 27 de mai. de 2026 · NCT03093116

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

  • University of Texas at Austin, Austin
  • Mary Crowley Cancer Research, Dallas
  • The University of Texas MD Anderson Cancer Center, Houston
  • e mais 1
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 15 de mai. de 2026 · NCT05379985

A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors

  • MD Anderson Cancer Center, Houston
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 22 de abr. de 2026 · NCT07020221

Molecular Epidemiology of Biliary Tree Cancers

  • M D Anderson Cancer Center, Houston
RecrutandoEstudo observacional
Todas as idades · Todos os sexos · Atualizado em 17 de abr. de 2026 · NCT05179486

Novel Rigidizing Overtube in Colonic Endoscopic Submucosal Dissection

  • Baylor College of Medicine, Houston
  • Baylor St. Lukes Medical Center (BSLMC), Houston
Recrutando
Idades 22 e acima · Todos os sexos · Atualizado em 24 de mar. de 2026 · NCT06134687

Traction vs. No Traction in Colonic ESD

  • Baylor College of Medicine, Houston
  • Baylor St. Lukes Medical Center (BSLMC), Houston
Recrutando
Idades 18 e acima · Todos os sexos · Atualizado em 24 de mar. de 2026 · NCT06159634

Prospective Data Registry and Quality of Life Assessment of Patients Undergoing Radiotherapy With the RefleXion Medical Radiotherapy System

  • UT Southwestern, Dallas
RecrutandoEstudo observacional
Todas as idades · Todos os sexos · Atualizado em 15 de ago. de 2025 · NCT05406167

Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.